Skip to main content

previous disabled Page of 2
and
  1. Article

    Author Correction: Developmental origins shape the paediatric cancer genome

    **aolong Chen, Wentao Yang, Charles W. M. Roberts, **ghui Zhang in Nature Reviews Cancer (2024)

  2. No Access

    Article

    Developmental origins shape the paediatric cancer genome

    In the past two decades, technological advances have brought unprecedented insights into the paediatric cancer genome revealing characteristics distinct from those of adult cancer. Originating from develo** ...

    **aolong Chen, Wentao Yang, Charles W. M. Roberts, **ghui Zhang in Nature Reviews Cancer (2024)

  3. Article

    Author Correction: Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF

    Sandi Radko-Juettner, Hong Yue, Jacquelyn A. Myers, Raymond D. Carter in Nature (2024)

  4. No Access

    Article

    Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF

    Whereas oncogenes can potentially be inhibited with small molecules, the loss of tumour suppressors is more common and is problematic because the tumour-suppressor proteins are no longer present to be targeted...

    Sandi Radko-Juettner, Hong Yue, Jacquelyn A. Myers, Raymond D. Carter in Nature (2024)

  5. No Access

    Article

    Mitotic bookmarking by SWI/SNF subunits

    For cells to initiate and sustain a differentiated state, it is necessary that a ‘memory’ of this state is transmitted through mitosis to the daughter cells13. Mammalian switch/sucrose non-fermentable (SWI/SNF) ...

    Zhexin Zhu, **aolong Chen, Ao Guo, Trishabelle Manzano, Patrick J. Walsh in Nature (2023)

  6. No Access

    Article

    cBAF complex components and MYC cooperate early in CD8+ T cell fate

    The identification of mechanisms to promote memory T (Tmem) cells has important implications for vaccination and anti-cancer immunotherapy14. Using a CRISPR-based screen for negative regulators of Tmem cell gene...

    Ao Guo, Hongling Huang, Zhexin Zhu, Mark J. Chen, Hao Shi, Su**g Yuan in Nature (2022)

  7. No Access

    Article

    A first-generation pediatric cancer dependency map

    Exciting therapeutic targets are emerging from CRISPR-based screens of high mutational-burden adult cancers. A key question, however, is whether functional genomic approaches will yield new targets in pediatri...

    Neekesh V. Dharia, Guillaume Kugener, Lillian M. Guenther in Nature Genetics (2021)

  8. Article

    Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumors

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Anton G. Henssen, Richard Koche, Jiali Zhuang, Eileen Jiang, Casie Reed in Nature Genetics (2020)

  9. No Access

    Article

    The SWI/SNF complex in cancer — biology, biomarkers and therapy

    Cancer genome-sequencing studies have revealed a remarkably high prevalence of mutations in genes encoding subunits of the SWI/SNF chromatin-remodelling complexes, with nearly 25% of all cancers harbouring abe...

    Priya Mittal, Charles W. M. Roberts in Nature Reviews Clinical Oncology (2020)

  10. Article

    Open Access

    Author Correction: BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    **aofeng Wang, Su Wang, Emma C. Troisi, Thomas P. Howard in Nature Communications (2019)

  11. Article

    Open Access

    BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors

    Bromodomain-containing protein 9 (BRD9) is a recently identified subunit of SWI/SNF(BAF) chromatin remodeling complexes, yet its function is poorly understood. Here, using a genome-wide CRISPR-Cas9 screen, we ...

    **aofeng Wang, Su Wang, Emma C. Troisi, Thomas P. Howard in Nature Communications (2019)

  12. No Access

    Article

    Mutational processes shape the landscape of TP53 mutations in human cancer

    Unlike most tumor suppressor genes, the most common genetic alterations in tumor protein p53 (TP53) are missense mutations1,2. Mutant p53 protein is often abundantly expressed in cancers and specific allelic vari...

    Andrew O. Giacomelli, ** Yang, Robert E. Lintner in Nature Genetics (2018)

  13. Article

    Erratum: PGBD5 promotes site-specific oncogenic mutations in human tumors

    Nat. Genet.; doi:10.1038/ng.3866; corrected online 24 May 2017 In the version of this article initially published online, the affiliations for Jiali Zhuang listed an incorrect present address instead of an equ...

    Anton G Henssen, Richard Koche, Jiali Zhuang, Eileen Jiang, Casie Reed in Nature Genetics (2017)

  14. No Access

    Article

    PGBD5 promotes site-specific oncogenic mutations in human tumors

    Alex Kentsis and colleagues identify somatic genomic rearrangements in primary human rhabdoid tumors characterized by deletions and inversions involving PGBD5-specific signal sequences at their breakpoints. Th...

    Anton G Henssen, Richard Koche, Jiali Zhuang, Eileen Jiang, Casie Reed in Nature Genetics (2017)

  15. Article

    Open Access

    The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers

    Genes encoding subunits of SWI/SNF (BAF) chromatin remodelling complexes are collectively altered in over 20% of human malignancies, but the mechanisms by which these complexes alter chromatin to modulate tran...

    Burak H. Alver, Kimberly H. Kim, ** Lu, **aofeng Wang in Nature Communications (2017)

  16. No Access

    Article

    ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice

    Charles Roberts and colleagues show that deletion of Arid1a from mouse intestinal epithelium results in invasive adenocarcinomas resembling human colorectal cancer. They further show that ARID1A loss impairs SWI/...

    Radhika Mathur, Burak H Alver, Adrianna K San Roman, Boris G Wilson in Nature Genetics (2017)

  17. No Access

    Article

    SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation

    Charles Roberts, Peter Park, Bradley Bernstein and colleagues examine the consequences of SMARCB1 loss on enhancer landscapes in human rhabdoid tumors. They show that SMARCB1 is essential for the integrity and...

    **aofeng Wang, Ryan S Lee, Burak H Alver, Jeffrey R Haswell, Su Wang in Nature Genetics (2017)

  18. No Access

    Article

    Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer

    Depletion of Smarcb1 activates the Myc network of signalling cascades, increasing protein metabolism and activation of survival pathways allowing highly aggressive Kras-independent pancreatic cancer cells to deve...

    Giannicola Genovese, Alessandro Carugo, James Tepper, Frederick Scott Robinson in Nature (2017)

  19. Article

    Open Access

    Integrated genetic and pharmacologic interrogation of rare cancers

    Identifying therapeutic targets in rare cancers remains challenging due to the paucity of established models to perform preclinical studies. As a proof-of-concept, we developed a patient-derived cancer cell li...

    Andrew L. Hong, Yuen-Yi Tseng, Glenn S. Cowley, Oliver Jonas in Nature Communications (2016)

  20. No Access

    Article

    Targeting EZH2 in cancer

    Roberts and Kim discuss the mechanistic roles played by EZH2 in cancer as well as efforts to therapeutically target this epigenetic modifier.

    Kimberly H Kim, Charles W M Roberts in Nature Medicine (2016)

previous disabled Page of 2